Effect of Aerobic Training Versus Resistance Training on Plasma Homocystiene in Diabetic Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this \[clinical trial\] is to \[ compare \] in \[ diabetic male patients \]. The main question to answer is : Will be any difference between aerobic exercises and resistance exercises in improving levels of homocysteine, cholesterol and insulin in diabetic patients? Participants will take their medications and group of them do aerobic exercises and another group do resistance training
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2022
CompletedFirst Submitted
Initial submission to the registry
April 26, 2023
CompletedFirst Posted
Study publicly available on registry
May 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2023
CompletedMay 6, 2023
April 1, 2023
1.1 years
April 26, 2023
April 26, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
homocystiene
Homocysteine was measured with an enzyme linked immunosorbent (ELISA) method. The upper limit of normal is 15 μmol/l
12 weeks of training
Secondary Outcomes (2)
insulin
12 weeks of training
cholestrol
12 weeks of trianing
Study Arms (2)
aerobic exercises group (group A )
EXPERIMENTAL20 male patients with diabetes mellites Attended the program of walking on treadmill for 12 weeks according to the following parameters. Exercise prescription: Intensity: started by 60-75% of target heart rate according to each patient response. Duration: Each session consisted of five minutes warming up firstly then 25-30 minutes time of session ended by five minutes cool down exercises Frequency: Three times / week (day after day) for 12 weeks
resistance exercises group (group B)
EXPERIMENTAL20 male patients with diabetes mellites will participate in resistance training exercises 30-45 mins. The subject will warm up and cool down for at least five to seven minutes each, (before and after exercise) with initial load of 60% of 1 repetition maximum. This program consists of 3 sets of 8 to 12 repetitions, then increasing load when subject was able to complete 12 repetitions. A rest period of 1.5 min was established between each set. Mode: 4 upper body exercises (bench press, seated row, shoulder press, and pull down), 3 leg exercises (leg press, extension, and flexion), abdominal crunches and back extensions. with the individualized workloads at 60% of 1RM. Duration: 30 min-45 min (total session). Frequency: Three times / week (day after day). Intensity: increased load was established when subject was able to complete 12 repetitions.
Interventions
aerobic exercises in form of walking on treadmill
60% of One-repetition maximum 3 sets ( 8 to 12 ) repetitions
Eligibility Criteria
You may qualify if:
- Their ages will range from 40 -55 years 2- Their body mass indexes will range between (25 to 35 Kg / m²). 3-All patients are diagnosed with type 2 diabetes mellites.
- Diagnostic criteria for type 2 diabetes were: 1) a fasting plasma glucose concentration of 7.0 mmol·L-1 or higher or 2) a plasma glucose concentration of 11.1 mmol·L-1 or higher two hours after an oral glucose challenge. (Punthakee et al.,2018).
- All subjects took oral hypoglycemic drugs but none of them were being treated with insulin when enrolled.
- All patients are medically and psychologically stable
You may not qualify if:
- Patients with uncontrolled blood glucose level
- Patients with unstable cardiovascular conditions (those with a known history of uncontrolled hypertension, ischemic attacks, stroke, congestive heart failure, currently on anticoagulation therapy) were excluded from this study.
- Patients with severe pulmonary disease (with restrictive lung disease or with obstructive lung disease).
- Patients with musculoskeletal disorders (Diagnosed with severe osteoporosis or severe osteoarthritis).
- Patients with BMI \> 35 will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Egyptian Chineese University
Cairo, Gesr Elsuez, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
hanan hassan
Egyptian Chinese University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer
Study Record Dates
First Submitted
April 26, 2023
First Posted
May 6, 2023
Study Start
April 4, 2022
Primary Completion
May 15, 2023
Study Completion
May 15, 2023
Last Updated
May 6, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- immediately following publication , no end data
- Access Criteria
- anyone who whishes to access the data, for any purpose
all of the individual participant data collected during the trail, after de-identification